In the pharmaceutical industry, Ibuprofen 400 mg is considered the “Standard Therapeutic Dose” for moderate pain and inflammation. As a pharmacist and manufacturer, I classify this as a highly effective Non-Steroidal Anti-Inflammatory Drug (NSAID) that is superior to paracetamol for pain accompanied by swelling or redness.
At your WHO-GMP facility in Mumbai, the 400 mg strength is likely your highest-volume Ibuprofen SKU, serving as a versatile product for both over-the-counter (OTC) and prescription markets.
Primary Clinical Efficacy
Ibuprofen 400 mg is “good” and clinically indicated for:
Musculoskeletal Pain: Excellent for backaches, sprains, and sports injuries.
Dental Pain: Often the first choice for post-procedural dental inflammation.
Dysmenorrhea: Highly effective at reducing the prostaglandins that cause menstrual cramping.
Headaches & Migraines: Provides rapid relief for tension-type headaches.
Arthritic Flare-ups: Manages acute episodes of joint pain and stiffness.
Mechanism: The COX Enzyme Blockade
Ibuprofen targets the underlying cause of pain—inflammation—rather than just masking the signal in the brain.
Inhibition: It inhibits the Cyclooxygenase (COX-1 and COX-2) enzymes.
Prostaglandin Reduction: By blocking these enzymes, it stops the conversion of arachidonic acid into prostaglandins, which are the chemical mediators that sensitize pain receptors and cause swelling.
Antipyretic Effect: It also acts on the hypothalamus to reduce fever.
The Pharmacist’s “Technical Warning”
As you promote your pharmaceutical firm on digital and social platforms, providing these technical insights is essential for professional authority:
The “Ceiling Effect”: For simple pain, increasing the dose beyond 400 mg may not provide significantly more relief but will increase the risk of side effects.
Gastric Safety: Advise taking the tablet with a full glass of water and after food to minimize the risk of stomach irritation or ulcers.
Asthma Caution: Approximately 10% of asthmatics may experience a “bronchospasm” when taking NSAIDs.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Universal Analgesic” USP: On your marketplace, highlight that your Ibuprofen 400 mg meets BP/USP/IP standards, ensuring rapid dissolution and predictable bioavailability—critical for international B2B buyers.
Packaging Strategy: For tropical export (Zone IVb), we utilize Alu-Alu or PVDC-coated PVC blisters to prevent the tablets from becoming brittle or discolored due to humidity.
FDC Opportunity: Consider promoting an Ibuprofen 400 mg + Paracetamol 325 mg combination. This “Dual-Action” formula is a high-growth segment in the global pain-management market.
Dossier Support: We provide full CTD/eCTD Dossiers to assist your firm in registering this product in emerging markets.